North America Microbiome Therapeutics Market
The North America Microbiome Therapeutics Market size was valued at US$ 161.64 Mn in 2022 and is projected to reach US$ 342.99 Mn by 2030, growing at a CAGR of 9.9% during 2022 - 2030.
Report Coverage
- Type: Therapeutics and Procedure
- Application: Metabolic Disorder and Obesity, C. Difficile Infection, Inflammatory Bowel Disease
- End User: Hospitals and Clinics, Ambulatory Surgical Centers, Homecare
US$ 161.64 Mn
Market size in 2022
US$ 342.99 Mn
Market Size by 2030
9.9%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Microbiome Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Microbiome Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Microbiome Therapeutics Market Regional Analysis
6.2 North America Microbiome Therapeutics Market Revenue 2020-2030 (US$ Million)
6.3 North America Microbiome Therapeutics Market Forecast Analysis
7. North America Microbiome Therapeutics Market Analysis – by Type
7.1 Therapeutics and Procedure
- 7.1.1 Overview
- 7.1.2 Therapeutics and Procedure: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Microbiome Therapeutics Market Analysis – by Application
8.1 Metabolic Disorder and Obesity
- 8.1.1 Overview
- 8.1.2 Metabolic Disorder and Obesity: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 C. Difficile Infection
- 8.2.1 Overview
- 8.2.2 C. Difficile Infection: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Inflammatory Bowel Disease
- 8.3.1 Overview
- 8.3.2 Inflammatory Bowel Disease: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Microbiome Therapeutics Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Homecare
- 9.3.1 Overview
- 9.3.2 Homecare: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Microbiome Therapeutics Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Microbiome Therapeutics Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 North America Microbiome Therapeutics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.1.2 US: North America Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.1.3 US: North America Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.2 Canada: North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.3 Mexico : North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Microbiome Therapeutics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AOBiome Therapeutics Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Ferring Holdings SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Finch Therapeutics Group Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Pendulum Therapeutics Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Seres Therapeutics Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
